A new framework aims to harmonize clinical trial data reporting across borders, boosting transparency and accelerating global drug …
A new framework aims to harmonize clinical trial data reporting across borders, boosting transparency and accelerating global drug …
FDA mandates clearer drug ads, Merck expands oncology portfolio, and political shifts raise questions about public health leadership.
Backed by top-tier investors, the new biotech aims to redefine psychiatric care with precision neurotherapeutics
Landmark Series A round positions Australian biotech at the forefront of neurodegenerative disease innovation.
The CGM giant and smart ring innovator join forces to integrate biosensor data and reshape personal health tracking.
Amgen’s MariTide leads the pack, while other candidates face setbacks in the competitive GLP-1RA landscape.
New molecular imaging techniques show promise in improving cancer surgery precision and outcomes.
Memorial Sloan Kettering researchers uncover how pancreatic cancer cells suppress immune triggers by manipulating genetic elements.
Gilead’s twice-yearly injectable PrEP shows near-perfect efficacy, prompting global access initiatives and a rethinking of HIV prevention strategies.
A new research center and FDA-backed diversity mandates aim to reshape clinical trial equity and representation across the …
